OSI PHARMA LOOKING FOR JAPAN TARCEVA OK

OSI Pharmaceuticals Inc. said Monday that its international marketing partner for the cancer drug Tarceva submitted a marketing application to get the drug approved in Japan.
The Houston Chronicle